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Abstract  32 
 33 
Neutrophils are abundant circulating leukocytes that are rapidly recruited to sites of 34 
inflammation in an integrin-dependent fashion. Contrasting with the well-characterized 35 
regulation of integrin activation, mechanisms regulating integrin inactivation remain largely 36 
obscure. Using mouse neutrophils, we demonstrate here that the GTPase activating protein 37 
ARAP3 is a critical regulator of integrin inactivation; experiments with Chinese hamster ovary 38 
cells indicate this is not restricted to neutrophils. Specifically, ARAP3 acts in a negative 39 
feedback loop downstream of PI3K to regulate integrin inactivation. Integrin ligation drives the 40 
activation of PI3K and of its effectors, including ARAP3, by outside-in signaling. ARAP3 in 41 
turn promotes localized integrin inactivation by negative inside-out signaling. This negative 42 
feedback loop reduces integrin-mediated PI3K activity, with ARAP3 effectively switching off its 43 
own activator, whilst promoting turnover of substrate adhesions. In vitro, ARAP3-deficient 44 
neutrophils display defective PIP3 polarization, adhesion turnover and transendothelial 45 
migration. In vivo, ARAP3-deficient neutrophils are characterized by a neutrophil-autonomous 46 
recruitment defect to sites of inflammation.  47 
 48 
 49 
Key points.  50 
1. A negative feedback loop, integrin-PI3K-ARAP3-integrin controls integrin inactivation 51 




Neutrophils are abundant leukocytes that are key to the inflammatory response and provide a 54 
first line of defense against infections. Upon stimulation, circulating neutrophils leave the blood 55 
stream to be recruited to sites of infection or injury, where they phagocytose and kill pathogens, 56 
releasing reactive oxygen species and other cytotoxic agents (1, 2). Inappropriately activated 57 
neutrophils can make important contributions to host injury.  58 
 59 
Integrins are a/b heterodimeric cell surface receptors that bind to extracellular matrix proteins 60 
and transmembrane receptors expressed by activated endothelial cells, bridging them to the 61 
cytoskeleton (3). In addition to the major b2 leukocyte integrins, neutrophils also express others, 62 
including the ubiquitous b1 integrins. Integrin ligation triggers ‘outside-in signaling’ to initiate 63 
intracellular signaling cascades. This is distinct from ‘inside out’ signaling, which refers to 64 
intracellular signaling events that regulate the integrin ligand binding affinity status. Whilst the 65 
mechanism of integrin activation is well characterized in leukocytes, the regulation of integrin 66 
inactivation remains largely elusive. 67 
 68 
As illustrated by leukocyte adhesion deficiencies, rare genetic diseases characterized by lacking, 69 
dysfunctional or activation-impaired b2 integrins, integrins are essential for neutrophil 70 
recruitment to sites and clearance of infections (4, 5). A large body of work identified how 71 
leukocyte integrins are activated in a mechanism that is crucial for neutrophil recruitment to 72 
inflamed sites. Proximally, this involves the adapters talin and kindlin-3 that directly bind to 73 
integrin cytoplasmic tails, promoting their activation (6, 7), with Rap and its effectors, RAPL, 74 
RIAM and Radil acting upstream. Excessive integrin activity has also been shown to interfere 75 
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with leukocyte recruitment (8, 9), but mechanisms governing integrin inactivation in this context 76 
remain poorly defined. 77 
 78 
Class I (agonist-activated) PI3Ks transduce signals through the generation of the lipid second 79 
messengers phosphatidylinositol 3,4,5-trisphosphate (PIP3) by phosphorylation of PI(4,5)P2 in 80 
the plasma membrane. Four class I PI3K isoforms exist and are expressed by the neutrophil, a, 81 
b, g and d (10). Class I PI3K isoforms are activated upon receptor ligation by SH2 domain 82 
binding to phosphotyrosine motifs in receptors or their adapters (e.g. in integrin outside-in 83 
signaling), G protein bg subunits as well as Ras/Rho family small GTPases. PIP3 causes the 84 
recruitment to the plasma membrane and activation of numerous PI3K effector proteins, 85 
including several regulators of small GTPases.  86 
 87 
ARAP3 is a PI3K and Rap-regulated GTPase activating protein (GAP) for RhoA and Arf6 that 88 
was identified as a PIP3 binding protein from pig neutrophils (11, 12). ARAP3 shares its domain 89 
structure with ARAP1/2 which differ in their expression profiles and substrate specificities (11, 90 
13-15). We previously showed ARAP3 to regulate adhesion-dependent processes in the 91 
neutrophil (16). The data presented here identify that integrin activation triggers a negative 92 
feedback loop downstream of PI3K by which ARAP3 promotes integrin inactivation. Despite 93 
focusing here on b1 integrins in neutrophils, we demonstrate that this function of ARAP3 is also 94 
broadly applicable elsewhere. As well as causing a polarization and chemotaxis defect in vitro, in 95 
vivo, ARAP3-deficiency interferes with efficient neutrophil recruitment to sites of inflammation.  96 
 97 
  98 
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Materials and Methods 99 
Unless indicated otherwise, cell culture reagents were from Gibco, cell culture plastics from 100 
Corning and all other materials from Sigma. All reagents were of the lowest available endotoxin 101 
grade. PI3K inhibitors (Selleckchem) and final concentrations used were; pan-PI3K, wortmannin 102 
(50nM); PI3Ka, BYL-719 (0.25µM); PI3Kb, TGX-221 (40nM); PI3Kd, IC87114 (1µM). 103 
 104 
Inducible Arap3-/-  mouse model 105 
To analyze neutrophils in vitro, 10-12 week old sex-matched Arap3fl/fl ERT2Cre+ mice were 106 
induced with a single intraperitoneal injection with 200mg/kg tamoxifen or vehicle, with 107 
experiments performed 10-12 days after induction as described (16). For in vivo experiments, 108 
age and sex matched Arap3fl/fl ERT2Cre+ mice and Arap3+/+ERT2Cre+ controls were subjected to 109 
5 successive gavages with emulsion containing 1.5mg tamoxifen, followed by a rest period of 10 110 
days (Fig S3A for an example). For ease of reading, tamoxifen induced Arap3fl/fl ERT2Cre+ mice 111 
(or neutrophils) are referred to in the text as ARAP3-deficient and in figures as -/-, whilst vehicle 112 
induced Arap3fl/fl ERT2Cre+ and tamoxifen induced Arap3+/+ERT2Cre+ controls are referred to as 113 
controls and +/+, with explanations provided in figure legends. All mice were housed in a 114 
specific pathogen-free small animal barrier unit at the University of Edinburgh. All animal work 115 
was approved by the University of Edinburgh Animal Welfare Committee and conducted under 116 
the control of the United Kingdom Home Office (PPL 60/4502 and PFFB 42579).  117 
 118 
Neutrophil preparations 119 
Bone marrow-derived mouse neutrophils were prepared on a discontinuous percoll gradient as 120 
previously described (17), using endotoxin reagents throughout, yielding ~70% purity as 121 
 
 6 
assessed by cytocentrifuge preparations. Unless stated otherwise, experiments were performed in 122 
Dulbecco’s PBS supplemented with Ca2+ and Mg2+, 1g/L glucose and 4mM sodium bicarbonate 123 
(‘PBS++’). 124 
 125 
Adhesion-induced neutrophil functions  126 
Tissue culture wells were coated overnight at 4°C with fibronectin as indicated. Surfaces were 127 
washed 3 times with PBS, blocked with 10% FBS in PBS, and washed again before addition of 128 
pre-warmed neutrophils. ROS production was measured indirectly using chemiluminescence 129 
produced by 5 x 105 neutrophils per well at 37°C with 150µM luminol and 18.75 U/mL HRP in 130 
the presence or absence of TNF-a (20ng/ml final concentration) in luminescence grade 96 well 131 
plates (Nunc) using a Cytation plate reader (Biotec) essentially as described (16). Where 132 
indicated, neutrophils were pre-incubated with inhibitors for 10 minutes at 37°C at the indicated 133 
concentrations. Where blocking peptides were employed, neutrophils were plated onto the 134 
immobilized stimuli and the competing peptide, such that both were encountered at the same 135 
time. Neutrophil adhesion, spreading and degranulation assays were as previously described 136 
(REF). For adhesion to endothelial cells, bEND5 cells were seeded into 24 wells, allowed to 137 
form confluent monolayers for 2 days and stimulated with 5nM TNF-a for 16 hours. After 138 
washing and careful aspiration, 100µl HBSS (with Ca2+ and Mg2+) containing 1 x 105 neutrophils 139 
were added and allowed to bind to the stimulated endothelial cells under gentle rocking. After 30 140 
minutes, non-adherent neutrophils were washed away with HBSS (without Ca2+ and Mg2+). 141 
Adherent neutrophils were fixed with PFA, labelled for GR1 (clone RB6-8C5, Biolegend) and 142 
counted in randomly taken frames (Evos imaging system; AMG/Thermo). Transendothelial 143 
migration towards the indicated concentrations of MIP2 (R&D Systems) for 1 hour in 6.5mm 144 
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transwell inserts with 3µm pore polycarbonate membranes (Corning) were performed as 145 
described (17). Transmigrated neutrophils were labelled for GR1, and 8 random fields of view 146 
were photographed and counted (20x magnification; EVOS imaging system).  147 
 148 
ARAP3 knock-down in aIIbb3-expressing CHO cells 149 
aIIbb3-expressing CHO cells were transduced with lentiviral shRNAs directed against mouse 150 
ARAP3. shRNA sequences (shRNA1, CTCCGGCTGGAAGGTGTATAT and 151 
GGAATCCGCAAGAAGTTAAA; shRNA2, GCAGAAGTGTGCGTCTCTAAA and 152 
TGTATGAAGAGCCAGTATATG), identified from the Broad Institute RNAi consortium 153 
database [https://portals.broadinstitute.org/gpp/public], were used alongside a non-targeting 154 
control (NTC; GCGCGATAGCGCTAATAATTT). Oligos were synthesized (Sigma Genosys), 155 
cloned into pLKO.1 (18), inserts sequenced, lentiviral particles generated, transduced CHO cell 156 
populations selected with puromycin. Samples were analyzed by Western blot using sheep anti 157 
ARAP3 antiserum (11) and anti-human CD41 (MAB7616, R&D Systems) with HSP90 (clone 158 
3H3C27, Biolegend) serving as loading control . 159 
 160 
CHO cell adhesion and spreading 161 
Trypsinized CHO cells in PBS++ were preincubated with inhibitors or vehicle for 10 minutes at 162 
37°C as indicated prior to being plated for 30 minutes onto glass coverslips that had been coated 163 
with 150µg/ml fibrinogen and blocked with 2% fatty-acid-free BSA. Fixed, washed cells were 164 
stained with AF568-conjugated phalloidin (Thermo Fisher); random images were acquired at 165 
20x magnification (EVOS imaging system). Prior to measuring cell areas with ImageJ, binary 166 




Direct analysis of integrin activity status 169 
Activated b1 integrin was detected using an activation epitope specific antibody (clone 9EG7; 170 
BD Biosciences) with an AF488-conjugated secondary (Invitrogen). Images were acquired with 171 
a 63x objective using a Zeiss LSM780 confocal microscope with Zeiss Zen Black software. The 172 
corrected total cellular fluorescence (CTCF) was calculated using ImageJ, by selecting regions 173 
for each cell, and nearby regions of background, and applying CTCF = integrated density – (area 174 
of selected cell x mean fluorescence of background readings).  175 
Neutrophil binding to an AF647-labelled fibronectin fragment was essentially as described (19) 176 
using flow cytometry using a 5L LSRFortessa (BD). Analysis was performed using FlowJo 177 
software (V10) by gating for singlets, selecting neutrophils based on forward and side scatter 178 
profile, and measuring geometric mean fluorescence intensity. Similarly, CHO cell binding to 179 
AF594-labelled fibrinogen (ThermoFisher) as well as activated and total aIIbb3 on trypsinized 180 
CHO cells were detected with fluorescently-conjugated antibodies (clones PAC-1, and A2A9.6 181 
respectively; Biolegend) and analyzed by measuring geometric mean fluorescence intensity of 182 
singlets.  183 
 184 
Indirect analysis of PI3K activity 185 
Neutrophil lysates were subjected to immunoblotting with an phosphospecific anti-PKB Thr308 186 
(clone C25E6, Cell Signaling Technology) essentially as described (17) with Syk used as loading 187 
control (clone 5F5, Biolegend). 188 
 189 
Analysis of GFP-PH-PKB reporter distribution 190 
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Micropipette chemotaxis assays were conducted, and polar plots were derived and overlaid using 191 
Anagraph (Simon Andrews, The Babraham Institute) and QuimP software [(20), Garching 192 
Innovation] as described (21).  193 
 194 
Neutrophil adhesion under laminar flow conditions  195 
Purified neutrophils were preincubated for 10 minutes at 37ºC with PI3K or vehicle as indicated 196 
prior to being perfused through flow chamber slides (Ibidi VI0.4) that had been coated with 197 
recombinant murine (rm) ICAM-1 (15µg/ml), rm P-selectin (10µg/ml; both Biolegend) and rm 198 
CXCL1 (10µg/ml; Biotechne) using a syringe pump (Legato 200, KD Scientific) to deliver a 199 
constant shear stress of 1 dyne / cm2 at 37 ºC. Adhesion under flow was recorded with 20x 200 
magnification by time lapse imaging (2.5 images / second) for 1 minute at 1, 5, 10 and 15 201 
minutes after starting the flow. This was done using a Leica IRB inverted microscope equipped 202 
with temperature controlled, automated stage (Prior), Orca camera (Hamamatsu) and 203 
Micromanager image acquisition software (FiJi). Firmly adherent cells were manually counted 204 
using ImageJ.  205 
 206 
Lipopolysaccharide-induced acute lung inflammation 207 
LPS-induced ALI was performed essentially as described (22). Some mice received 3µg APC-208 
anti CD45 (30-F11, Biolegend) in 100µl sterile PBS intravenously 15 minutes prior to being 209 
sacrificed, 4 hours after LPS administration, such that in lung digest samples, neutrophils could 210 
be stratified by CD45+ and CD45- staining, indicating vascular or interstitial cells, respectively. 211 
Lungs were slowly perfused through the right ventricle with 10ml saline, and a portion of the 212 
right inferior lobe collected for single cell digestion with collagenase (Roche) and subsequent 213 
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analysis. BAL cells were counted (NucleoCounter, Sartorius). BAL cells and lung digests were 214 
labelled with FITC-anti GR1 and APC-anti CD11b (Biolegend) and analyzed by flow cytometry  215 
to calculate total neutrophil numbers (GR1high, CD11b+). For imaging, lungs were perfused with 216 
low melting point agarose, allowed to set on ice, dissected and fixed with formaldehyde. Left 217 
lungs were precision sliced 300µm thick using a vibratome (Campden Instruments 5100mz), 218 
permeabilized, blocked and labelled for PECAM-1 (clone 2H8, Abcam) and S100A9/MRP14 219 
(Hycult Biotech) with DAPI counterstaining. Following brief formaldehyde post-fixation, slices 220 
were mounted using Mowiol containing 2.5% w/v DABCO in gaskets and analyzed using a 221 
confocal laser scanning microscope to produce tile-scanned z-stacks (Zeiss LSM 880 NLO 222 
Airyscan Fast, using a 20x plan Apo 1.0N.A. water immersion objective, 405, 488 and 561nm 223 
cw lasers and acquiring in Airyscan Fast mode). Image analysis was performed using IMARIS 224 
software (ver 8 and 9, Bitplane, Oxford Instruments). Endothelial surfaces (PECAM-1+) were 225 
rendered to allow identification of airway, interstitital or vascular compartments. Vascular and 226 
perivascular neutrophils (S100A9+) were counted and normalized to the total volume of the 227 
vasculature.  228 
 229 
Statistical analysis  230 
Where data met the assumptions for parametric tests, two-tailed students’ t-test, or 1-way 231 
ANOVA with Bonferroni-corrected post hoc comparisons were used. Otherwise, the non-232 
parametric Mann-Whitney rank sum test was used for comparisons. For multiple comparisons, 233 
ANOVAs with Bonferroni-corrected post hoc comparisons were used. For kinetic experiments 234 
(ROS production) the area under the curve was calculated excluding baseline measures, and 235 
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comparisons were made using a two-tailed students’ t-test. P values < 0.05 were considered 236 
statistically significant.   237 
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Results  238 
We previously described an embryonically lethal Arap3 knock-out mouse (23), and a tamoxifen-239 
inducible system for the analysis of ARAP3-deficient neutrophils. Apart from leukocyte-specific 240 
b2 integrins neutrophils express many others, including ubiquitous b1 integrins that are involved 241 
in interactions with extracellular matrix components such as fibronectin and vitronectin. In 242 
keeping with our earlier work we observed enhanced effector functions, including adhesion, 243 
spreading, ROS production and degranulation, with ARAP3-deficient neutrophils that had been 244 
plated onto fibronectin with co-stimulation by TNF-a (Fig S1A-G), but not upon stimulation 245 
with formylated peptides (16). This implies that ARAP3 is an important regulator of neutrophil 246 
functions downstream of b1 integrin ligation.  247 
 248 
ARAP3 promotes neutrophil b1 integrin inactivation 249 
To ascertain whether the hyper-stimulatory effect of fibronectin binding on ARAP3-deficient 250 
neutrophils was due to integrin activity, we made use of a blocking peptide, GRGDSPK, that has 251 
been shown to compete with fibronectin binding (24, 25). GRGDSPK, but not a control peptide 252 
with disrupted RGD motif, interfered with ROS production induced by plating control and 253 
ARAP3-deficient neutrophils onto fibronectin-coated plastic in the presence of TNF-a in a 254 
concentration-dependent fashion (Fig 1A).  255 
 256 
Increased integrin abundance might explain such increased responses. We did, however, not 257 
observe any increased surface integrin expression with ARAP3-deficient neutrophils [Fig S1H,J 258 
and not shown; (16)].  An alternative explanation would be an activated integrin conformation 259 
present in ARAP3-deficient neutrophils. We analyzed binding of suspension control and 260 
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ARAP3-deficient neutrophil to a fluorescently tagged soluble fibronectin fragment. In the 261 
presence of 1mM Mg++, ARAP3-deficient neutrophils exhibited a significant increase in 262 
fibronectin fragment binding compared to controls (Fig 1B,C). We also employed an antibody 263 
that binds to an activation epitope present on both human and mouse b1, 9EG7. We plated 264 
control and ARAP3-deficient neutrophils onto fibronectin in the presence of TNF-a and 265 
observed significantly increased 9EG7 binding with ARAP3-deficiency (Fig 1D,E). We 266 
concluded that ARAP3 promotes integrin inactivation in the neutrophil. 267 
 268 
ARAP3 promotes inactivation of heterologous human aIIbb3 and endogenous integrins in 269 
Chinese hamster ovary cells. 270 
ARAP3 expression is restricted to some myeloid cells and the vasculature in the mouse (not 271 
shown), but it is more broadly expressed in epithelial cells in some other organisms (11). To 272 
establish whether ARAP3-mediated integrin inactivation is restricted to the neutrophil, we used 273 
Chinese hamster ovary (CHO) cells, that had been engineered to express the human platelet 274 
integrin aIIbb3 (26). Taking advantage of the high degree of conservation between hamster and 275 
mouse ARAP3 (92% cDNA identity), we generated two ARAP3 knock-down CHO cell 276 
populations by expressing distinct pools of mouse ARAP3-targeting shRNAs alongside a 277 
population expressing a non-targeting control (NTC) shRNA (Fig 2A).  278 
 279 
Surface (but not total) human aIIbb3 was reduced in both ARAP3 knock-downs (Fig 2A-D). To 280 
test whether ARAP3 regulates the activity status of the heterologous aIIbb3 in CHO cells, we 281 
measured binding to fluorescently labelled fibrinogen by suspension CHO cells by flow 282 
cytometry. Increased fibrinogen binding was observed with both ARAP3 knock-down 283 
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populations (Fig 2E, F). Moreover, by employing the activation epitope-specific antibody PAC-284 
1, we noted that the proportion of activated out of total surface aIIbb3 was increased in ARAP3 285 
knock-down cells (Fig 2G), consistent with the notion that ARAP3 regulates inactivation of 286 
heterologous human aIIbb3 integrin in CHO cells, too. 287 
 288 
In cancer cells, increased b1 integrin activity correlates with increased spreading (19). As 289 
indirect read-out of integrin activity we therefore also measured the areas occupied by CHO cells 290 
that had been plated onto fibrinogen (Fig 2H, J). ARAP3 knock-down CHO cells occupied a 291 
significantly larger area than NTC expressing CHO cells, again indicative of ARAP3-dependent 292 
control of CHO cell integrins. Preincubating the cells with aIIbb3 blocking abciximab 293 
significantly reduced the area occupied by control and ARAP3 knock-down CHO cells, 294 
suggesting that heterologous aIIbb3 mediated most fibrinogen binding. Interestingly, however, 295 
abciximab-preincubated ARAP3 knock-down cells remained more spread than controls, 296 
suggesting that ARAP3 inactivates not only aIIbb3, but also endogenous hamster integrins that 297 
were also capable of binding fibrinogen without being affected by the blocking antibody. 298 
Inhibiting PI3K significantly reduced the areas occupied by control and ARAP3 knock-down 299 
CHO cells. No significant difference remained between experimental groups after treatment with 300 
wortmannin. These observations are in keeping with ARAP3 being a PI3K effector that is able to 301 
regulate many integrins, including heterologous human aIIbb3 in CHO cells. 302 
 303 
ARAP3 acts in a negative feedback loop downstream of integrin and PI3K 304 
Having established that ARAP3 mediates integrin inactivation, we turned our attention to 305 
upstream signaling. In the neutrophil, ARAP3’s master regulator PI3K is activated by integrin 306 
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outside-in signaling downstream of Src family kinases / Syk (27), with PI3Kb and d isoforms 307 
implicated in mediating integrin-dependent responses (28).  308 
 309 
To probe the relationship between integrin, PI3K and ARAP3, we analyzed ROS production 310 
with neutrophils that had been plated onto fibronectin in the presence or absence of TNFa. 311 
Integrin ligation-induced ROS depends on PIP3 generation through class I PI3K, in particular 312 
PI3Kb and d (28), whilst SHIP1 (29) or ARAP3 (Fig 1) deficiency causes increased adhesion-313 
dependent ROS. Inhibiting individual class IA PI3K isoforms reduced adhesion-induced ROS 314 
production observed with control and ARAP3-deficient neutrophils, and abrogated significant 315 
differences observed between genotypes (Fig 3A). 316 
 317 
ROS production is dependent on PIP3-activated Rac GEFs, inhibition of which could potentially 318 
explain the above result. We therefore also analyzed PI3K-dependency of degranulation with 319 
control and ARAP3-deficient neutrophils that been stimulated by being plated onto fibronectin in 320 
the presence of absence of TNFa. Inhibiting class IA PI3Ks, also reduced the enhanced 321 
degranulation that is characteristic of ARAP3-deficient cells; in particular, following PI3Kd 322 
inhibition no significant difference remained between genotypes (Fig 3B).   323 
 324 
We analyzed adhesion and spreading of control and ARAP3-deficient neutrophils after PI3K 325 
inhibition to fibronectin-coated plastic. Inhibiting PI3Kb/d did not significantly affect the ability 326 
of neutrophils to adhere to fibronectin, in keeping with an earlier report that had analyzed 327 
neutrophil adhesion to immobilized immune complexes [(28) and not shown]. However, it 328 
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resulted in compromised neutrophil spreading in both genotypes, putting an end to significant 329 
differences between them (Fig 3C). 330 
 331 
Finally, we compared adhesion of neutrophils under constant flow in parallel-plate flow 332 
chambers. As previously reported (16), we noted increased neutrophil adhesion with ARAP3-333 
deficient neutrophils compared to controls. Preincubating the neutrophils with a PI3Kb-specific 334 
inhibitor caused decreased neutrophil adhesion in both genotypes (Fig 3D). Notably, this 335 
abolished the significant difference in adhesion observed between genotypes in the absence of 336 
inhibitor treatment. Together these results show that ARAP3 acts downstream of PI3K in 337 
neutrophil adhesion and adhesion-dependent neutrophils functions. Given the heightened 338 
responses observed with ARAP3-deficient neutrophils, they also suggest the existence of a 339 
negative feedback loop.  340 
        341 
For experimental evidence of this feedback loop, we analyzed PKB/Akt Thr308 phosphorylation 342 
as an indirect read-out for PI3K activity with neutrophils that did or did not express ARAP3. 343 
PKB Thr308 phosphorylation was increased more dramatically in ARAP3-deficient than control 344 
neutrophils that had been plated onto the synthetic integrin ligand polyRGD (Fig 3E, F). In 345 
contrast, ARAP3-deficiency did not confer increased PKB Thr308 phosphorylation in 346 
neutrophils that had been stimulated with the soluble agonist fMLF (Fig 3G, H). We concluded 347 
that ARAP3 functions in a negative feed-back loop specifically downstream of integrin-348 




Integrin-PI3K-ARAP3 negative feedback signaling regulates persistent neutrophil 351 
polarization during chemotaxis. 352 
Chemotaxing neutrophils are characterized by polarized PIP3 at the pseudopod (30, 31). To 353 
analyze whether the negative feedback loop delineated here operates to control neutrophil 354 
behavior, we analyzed PIP3 generation in the chemotaxing neutrophil in a spatiotemporal 355 
fashion. Having crossed inducible ARAP3 knock-out mice with mice that expressing a PIP3 356 
probe, GFP-PKB-PH  (30), we used confocal microscopy to monitor PIP3 production in real-357 
time in control and ARAP3-deficient neutrophils that were allowed to chemotax on glass 358 
coverslips towards fMLF. Control cells displayed persistent PIP3 polarization towards the 359 
chemoattractant. In contrast, ARAP3-deficient cells were unable to polarize PIP3 persistently, 360 
with poles observed to move around cells; more than 50% of ARAP3-deficient neutrophils 361 
exhibited additional pole(s) (Fig 4A for an example). We generated polar plots (21, 31), to 362 
visualize PIP3 polarization over time in individual neutrophils (not shown). Overlays of these 363 
polar plots confirmed the poor persistency of PIP3 polarization of ARAP3-deficient neutrophils 364 
(Fig 4B).  365 
 366 
In the absence of a probe for activated integrins, we were unable to test whether non-persistent 367 
PIP3 polarization of ARAP3-deficient neutrophils coincided with poor turnover of activated 368 
integrins. Fixed, adherent fMLP bath-stimulated control and ARAP3-deficient neutrophils were 369 
characterized by polarized activated b1 integrin staining at the pseudopod where it coincided 370 
with f-actin (Fig S2). For efficient forward motion of the neutrophil, these adhesions must be 371 
short-lived. Since ARAP3 is recruited to the plasma membrane by PIP3 (11), it is well placed to 372 
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be involved in localized integrin inactivation, ensuring persistence of polarization and 373 
directionality.  374 
 375 
ARAP3 regulates neutrophil transendothelial migration and recruitment to sites of 376 
inflammation. 377 
We next determined the requirement for ARAP3-dependent integrin inactivation in neutrophil 378 
recruitment to inflammatory sites. Whereas interstitial migration is thought to be integrin-379 
independent, barriers need to be overcome in an integrin-dependent fashion for neutrophil 380 
recruitment, e.g. during transendothelial migration. We first addressed whether the increased 381 
integrin activity of ARAP3-deficient neutrophils influences interactions with endothelial cells 382 
and transendothelial migration efficiency in vitro. As expected, we found that ARAP3-deficient 383 
neutrophils adhered more strongly than controls to monolayers of activated endothelial cells (Fig 384 
5A). Furthermore, ARAP3-deficient neutrophils were characterized by impaired migration to 385 
chemoattractant in a model for transendothelial migration, where transwells supported a 386 
monolayer of TNFa-stimulated endothelial cells (Fig 5B). In contrast, ARAP3-deficient 387 
neutrophils were not defective in transwell chemotaxis (Fig 5C), in line with our previous 388 
findings. Together this suggested that ARAP3-dependent integrin inactivation might be relevant 389 
for neutrophil recruitment in vivo. 390 
 391 
We therefore analyzed neutrophil recruitment in response to LPS-induced acute lung 392 
inflammation (ALI) in control and ARAP3-deficient mice. We noted significantly reduced 393 
neutrophil numbers in bronchoalveolar lavages from ARAP3-deficient mice compared with 394 
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controls (Fig 6A). This held true with bone marrow chimeras, identifying the recruitment defect 395 
as neutrophil-autonomous (Fig 6B).   396 
 397 
To reach the alveolar space, neutrophils have to breach two barriers, the capillary wall and the 398 
alveolar epithelium. To differentiate between neutrophils that were firmly adherent to the 399 
luminal side of the vessel wall or undergoing transendothelial migration and those that were 400 
interstitial (i.e. that had extravasated but not yet breached the epithelial barrier), we generated 401 
precision slices of agarose-perfused, inflamed lung tissue, labelling endothelium and neutrophils. 402 
Microscopical analysis of such lung slices suggested that larger numbers of ARAP3-deficient 403 
neutrophils had adhered to the lung vasculature and/or were in the process of transmigrating in 404 
ARAP3-deficient lungs (Fig 6C, D). We also used flow cytometry for a separate, higher powered 405 
quantitative approach to the same question. Mice were administered a fluorescently conjugated 406 
anti-CD45 antibody intravenously, labelling fully or partially intravascular leukocytes 407 
immediately prior to harvesting PBS-perfused, LPS-inflamed lungs for analysis of tissue 408 
homogenates. This identified significantly increased numbers of ARAP3-deficient neutrophils 409 
(but not macrophages) which had firmly adhered to the vessel wall or were actively 410 
transmigrating at the time of perfusion (Fig 6E; S3B, C). We concluded that ARAP3-mediated 411 
neutrophil integrin inactivation enables efficient transendothelial migration, promoting 412 
neutrophil recruitment in vivo.   413 
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Discussion  414 
The present work identifies ARAP3 as a regulator of integrin inactivation in the neutrophil and 415 
elsewhere. Our findings place ARAP3 downstream of PI3K in a negative feedback loop that 416 
promotes integrin inactivation (Fig 7). This mechanism enables rapid switching off of integrins 417 
following ligand binding-induced outside-in signaling. This feedback loop operates in adherent 418 
neutrophils, where ARAP3-dependent neutrophil activities are entirely dependent upon outside-419 
in signaling-induced upstream PI3K activity. ARAP3 deficiency results in increased integrin 420 
activity, which in turn causes increased integrin-induced PI3K activation and downstream 421 
events.  422 
 423 
We used integrin-dependent neutrophil chemotaxis as an experimental system in which to 424 
analyze the integrin-PI3K-ARAP3-integrin negative feedback loop in a spatiotemporal fashion. 425 
ARAP3-deficient neutrophils that chemotaxed on glass towards a point source of 426 
chemoattractant polarized PIP3 and generated pseudopods, but these were not persistently 427 
directed towards the source of chemoattractant; ARAP3-deficient neutrophils frequently 428 
displayed two (or more) poles. This is consistent with the poor integrin-dependent chemotactic 429 
migration of these cells (16). In chemotaxis on a 2D matrix, class I PI3Ks are activated 430 
downstream of chemoattractant-induced GPCR signaling but also by integrin outside-in 431 
signaling. Our results suggest that ARAP3 signaling is engaged to regulate integrin inactivation 432 
in response to integrin (but not GPCR) stimulation downstream of PI3K. Our observations are 433 
consistent with the possibility that ARAP3 might simply be recruited to PIP3 in the polarized 434 
neutrophil to inactivate integrin signaling in a spatiotemporally controlled fashion, limiting 435 
further integrin-dependent localized activation of PI3K and enabling pseudopod extension. 436 
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Alternatively, further player(s) such as PIP3 metabolizing enzyme(s) might also be recruited to 437 
the pseudopod to actively dephosphorylate PIP3. The functions of two PIP3 phosphatases, PTEN 438 
and SHIP1, have been analyzed in chemotaxis (29, 30, 32, 33). SHIP1 is activated and functions 439 
in adherent neutrophils, where it regulates neutrophil spreading, chemotaxis and PIP3 440 
polarization, whereas PTEN is thought to regulate other features.  441 
 442 
Physiologically, interstitial neutrophil migration is thought to be integrin-independent, whereas 443 
transendothelial migration is integrin-dependent, with some variability depending on capillary 444 
bed and stimulus (1, 2, 34). Our work suggests that in these situations ARAP3-dependent 445 
neutrophil integrin inactivation regulates efficient neutrophil recruitment to inflammatory sites 446 
by promoting neutrophil extravasation. This identifies that neutrophil extravasation not only 447 
requires activation of integrins, but moreover relies on their subsequent inactivation. The 448 
existence of an integrin inactivation step that regulates efficient immune responses had been 449 
predicted by an earlier report, where rendering aLb2 constitutively active genetically delayed T 450 
cell recruitment (9). Similarly, rendering aMb2 constitutively active using a small molecule 451 
interfered with efficient neutrophil recruitment to inflammatory sites (8). Given that ARAP3 is 452 
highly expressed in neutrophils, but not in lymphocytes (11), we speculate that integrin 453 
inactivation in lymphocytes is controlled by alternative mechanism(s). Given that ARAP1/2 are 454 
already implicated in the control of adhesion-dependent processes elsewhere (35, 36), and are 455 
expressed in lymphocytes (SV, unpublished), other ARAP family member(s) might be involved.   456 
 457 
In addition to demonstrating ARAP3-dependent inactivation of neutrophil b1 integrins, our work 458 
shows indirectly that ARAP3 also regulates neutrophil integrins that bind to substrates other than 459 
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fibronectin [e.g. vitronectin, fibrinogen, ICAM-1; not shown and (16)]. ARAP3 moreover 460 
inactivated heterologous human aIIbb3 as well as endogenous hamster integrins in CHO cells, 461 
again in a PI3K-dependent fashion. Given that ARAP3 is expressed in CHO cells, but not in 462 
platelets (which express ARAP2; IH & SV, unpublished), aIIbb3 is not a likely bona fide 463 
ARAP3 ‘substrate’. Rather, these observations suggest a more general function of ARAP3 464 
downstream of PI3K in integrin inactivation. This is interesting given ARAP3’s crucial function 465 
in developmental sprouting angiogenesis and lymphangiogenesis (23, 37), processes that are not 466 
only absolutely dependent upon integrins (38) but also heavily reliant on chemotaxis, with 467 
endothelial cells migrating collectively towards VEGF. It would be interesting to test to which 468 
extent the crucial role of ARAP3 downstream of PI3K in sprouting angiogenesis is linked to 469 
integrin inactivation. 470 
 471 
Integrin inactivation remains incompletely understood. Several scaffold proteins were shown to 472 
compete with talin for binding to integrin cytoplasmic tails in what appears to be a cell type-473 
specific fashion. DOK-1 (39, 40) and Filamin-A (41, 42) binding to the b2 cytoplasmic 474 
interfered with b2 integrin activation, affecting neutrophil chemotaxis and recruitment. 475 
Similarly, SHARPIN binding to b2 in lymphocytes interfered with aLb2 adopting high affinity 476 
or intermediate ligand binding conformations, with its loss reducing adhesion turnover, in vitro 477 
migration and delaying homing in vivo (43). Further studies will be required to determine which, 478 
if any, of these scaffold proteins are involved in PI3K-ARAP3 mediated integrin inactivation. 479 
 480 
  481 
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Figure Legends  656 
Figure 1. ARAP3 promotes β1 integrin inactivation in neutrophils. Neutrophils were prepared from 657 
bone marrows of mock (+/+) and tamoxifen induced (-/-) inducible Arap3 knock-out mice. (A) ROS 658 
production was analyzed with neutrophils that had been plated onto 20 µg/ml fibronectin in the presence 659 
of absence of 20 ng/ml TNFa together with the indicated concentration of the RGD blocking peptide 660 
GRGDSPK or the control peptide GRADSP. Results obtained in 4 separate experiments are combined in 661 
this graph. (B, C) Binding of control and ARAP3-deficient neutrophils to a fluorochrome-coupled 662 
fibronectin fragment was determined by flow cytometry. A representative experiment (B) and the 663 
integrated results from 4 separate experiments (C) are presented. (D, E) Neutrophils were allowed to 664 
adhere to fibronectin coated coverslips, fixed and immunostained with a β1 activation epitope-specific 665 
antibody. Representative confocal images with corresponding heatmaps of the fluorescence intensity are 666 
shown (D); scale bar, 5 µm. (E) Integrated results obtained with 9-18 cells analyzed per genotype from 3 667 
separately performed experiment are plotted. All bar graphs show mean ± SEM; * P<0.05; ** P<0.01; P-668 
values were calculated by unpaired two-tailed Student’s t-tests.  669 
 670 
Figure 2. ARAP3 promotes inactivation of heterologous human aIIbβ3 integrin in CHO cells.  (A) 671 
CHO cells were transduced to express 2 distinct pools of shRNAs directed against mouse ARAP3, or a 672 
non-targeting control (NTC). A representative Western blot is shown; HSP90 served as a loading control. 673 
(B, C) Surface aIIbβ3 on CHO cell populations was determined by flow cytometry. A representative 674 
example (B) and integrated results from 3 separately performed experiments are plotted (C). (D) 675 
Integrated results from 3 separately performed Western blots for total cellular aIIbβ3 expression. (E, F) 676 
CHO cell binding to fluorescently tagged fibrinogen was analyzed in suspension cultures. A 677 
representative example is shown (E) together with results integrated from at least 5 separately performed 678 
experiments (F). (G) Activation epitope specific PAC1 staining normalized to the total cell surface aIIbβ3 679 
in each cell population. Integrated results from 3 separately performed experiments are presented. (H, J) 680 
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Control and ARAP3 knock-down aIIbβ3 expressing CHO cells that had or had not been preincubated 681 
with the aIIbβ3 blocking antibody abciximab or the pan-PI3K inhibitor wortmannin, as indicated, were 682 
allowed to adhere to fibrinogen-coated coverslips. Random images were taken and the cell areas 683 
analyzed. Results from 4-7 separate experiments are plotted (H) together with representative images (J). 684 
Scale bar, 20µm. All bar graphs show mean±SEM. Raw data were analyzed for statistical significance. 685 
*P<0.05; ** P<0.01; ***P<0.001. P-values were calculated by 1-way ANOVA with Bonferroni-corrected 686 
post-hoc testing (C, D, F, G), and data were analyzed by 2-way ANOVA with Bonferroni post-hoc test, 687 
respectively (H). Significant differences between treatments of the same populations are indicated above 688 
the individual bars with color-coded symbols (#) whilst difference between NTC control and shRNA 689 
expressing cells within each condition are indicated by symbols (*) above brackets. 690 
 691 
Figure 3. A negative feedback loop involving integrin, PI3K and ARAP3. Neutrophils were prepared 692 
from bone marrows of mock (+/+) and tamoxifen induced (-/-) inducible Arap3 knock-out mice and (A-693 
D) preincubated with PI3K inhibitors or vehicle controls as indicated. (A) ROS production and (B) 694 
gelatinase release were analyzed with neutrophils that had been plated onto 20 µg/ml fibronectin in the 695 
presence of absence of 20 ng/ml TNFa. Graphs combine results from 4 separate experiments. (C) 696 
Neutrophils were allowed to adhere for 20 minutes to 5µg/ml fibronectin-coated tissue culture plastic in 697 
the presence or absence of 20ng/ml TNFa for analysis of spreading. Results obtained in 3 separate 698 
experiments are integrated in this graph. (D) Neutrophil adhesion under flow. Neutrophils were perfused 699 
at constant shear stress through ICAM1, p-selectin and CXCL1-coated flow chambers as detailed in 700 
Materials and Methods. Results obtained in at least 5 separate experiments are combined in the graph 701 
shown. (E, F) Neutrophils were allowed to adhere to tissue culture dishes that had been coated with heat 702 
inactivated FCS (HI-FCS) or a synthetic pan integrin ligand, polyArgGlyAsp (pRGD) for 15 minutes at 703 
37°C. (G, H) Suspension neutrophils were stimulated with 1µM fMLF for the indicated length of time. 704 
Lysates were subjected to SDS-PAGE and Western blots for probing with a phosphospecific Akt/PKB 705 
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antibody (Thr308) as well as a loading control (Syk). Representative blots are shown (D, F) and results 706 
obtained from 4 separately performed experiments are plotted (E, G). All graphs show mean ± SEM; * 707 
P<0.05; ** P<0.01; (A-C) were analysed by 1-way ANOVA with multiple comparison post-hoc test; (D, 708 
H) were analysed by 2-way ANOVA with Bonferroni multiple comparison test. Pairwise comparisons (F) 709 
were calculated from raw data by unpaired two-tailed Student’s t-tests. (A, F, H) Analyses were 710 
performed on the raw data. Symbols in graphs (A-D) refer to differences between control and ARAP3-711 
deficient neutrophils (in the absence of inhibitor treatment). No significant differences between genotypes 712 
were identified in (H).   713 
 714 
Figure 4. Integrin-PI3K-ARAP3 negative feed-back signaling aids neutrophil polarization. 715 
Neutrophils were prepared from bone marrows of mock (+/+) and tamoxifen induced (-/-) inducible 716 
Arap3 knock-out mice expressing a GFP-PKB-PH PIP3 reporter. Cells were allowed to settle on a glass 717 
coverslip, and then subjected to a point source of chemoattractant (micropipette). Cells were imaged using 718 
a Perkin Elmer spinning disk Nikon Eclipse TE2000E confocal microscope using a 100x oil immersion 719 
objective. Images were acquired every second for 5 minutes using a Hamamatsu cooled CCD camera. (A) 720 
Stills taken from a representative control and ARAP3-deficient neutrophil. (B) The distribution of the 721 
PIP3 probe along the edge of each frame of the movie was analyzed using QuimP software, measuring the 722 
image intensity at 100 nodes around the plasma membrane. The signal intensity along the membrane was 723 
normalized to that within the cell body. Intensity measurements were plotted using Anagraph, with each 724 
frame mapped onto a concentric ring and signal intensity represented by color coding to generate polar 725 
plots. The images shown represent overlays of polar plots generated with 25 control, and 24 ARAP3-726 
deficient neutrophils originating from 6 individual animals per genotype.  727 
 728 
Figure 5. ARAP3-regulated integrin inactivation promotes transendothelial migration in vitro. 729 
Neutrophils were prepared from bone marrows of mock (+/+) and tamoxifen induced (-/-) inducible 730 
Arap3 knock-out mice. Neutrophil adhesion (A) to activated mouse endothelial (bEND5) cells. 731 
 
 32 
Neutrophil transendothelial migration and chemotaxis (B, C) towards the indicated concentrations of 732 
chemoattractant in transwells that did (B) or did not (C) support a monolayer of activated bEND5 cells. 733 
Graphs integrate data obtained from of 3-4 separate experiments. All bar graphs show mean±SEM. * 734 
P<0.05; ** P<0.01. Pairwise comparisons were analyzed by unpaired two-tailed Student’s t-tests.  735 
 736 
Figure 6. ARAP3 promotes neutrophil recruitment and transendothelial migration in a model of 737 
acute lung injury. Cre was induced by repeat tamoxifen dosing inducible Arap3 knock-out (-/-) and 738 
inducible Cre mice (+/+), or their bone marrow chimeras as indicated. (A, B) ALI was induced in control 739 
and ARAP3-deficient mice (A) or their bone marrow chimeras (B) by intracheal administration of LPS. 740 
Neutrophil numbers retrieved from bronchoalveolar lavages (BAL) are plotted. (C, D) Agarose-perfused, 741 
LPS-inflamed lungs were fixed, precision sliced and endothelium, neutrophils and nuclei labelled. 742 
Representative examples of rendered, confocal image stacks are presented (C). Solid arrowheads, alveolar 743 
neutrophils; unfilled arrowheads, transendothelial / vascular firmly adherent neutrophils. (D) Images 744 
taken from 2 mice/genotype were analyzed and neutrophils that were adhering to the vasculature or 745 
actively transmigrating counted. Plotted numbers are normalized to the area of vasculature in the 746 
respective images. (E) Mice were intravenously administered fluorescently coupled anti-CD45 prior to 747 
lavaging of perfused lungs. Vessel-associated, CD45-labelled neutrophils in lung digests are plotted. (A, 748 
B, E) Each symbol representative of one mouse; graphs combine data obtained on at least 2 separate 749 
occasions. All bar graphs show mean±SEM. * P<0.05; ** P<0.01. P values were calculated by unpaired 750 
two-tailed Student’s t-tests.  751 
 752 
Figure 7. ARAP3 boosts integrin inactivation in a feed-back loop downstream of PI3K in the 753 
neutrophil. Schematic depicting how integrin-mediated outside-in signaling activates PI3K to activate 754 
ARAP3, which in turn regulates integrin inactivation by negative inside-out signaling in a negative feed-755 
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